Neha Mathur

Neha Mathur

MSc Biotechnology

Neha is a digital marketing professional based in Gurugram, India. She has a Master’s degree from the University of Rajasthan with a specialization in Biotechnology in 2008. She has experience in pre-clinical research as part of her research project in The Department of Toxicology at the prestigious Central Drug Research Institute (CDRI), Lucknow, India. She also holds a certification in C++ programming.

See more

She started her career as a content writer and over the years, earned extensive experience in writing, working with companies in diverse sectors, including Information Technology, Intellectual Property, a naval architectural company, and a payment wallet company.

She has conceptualized and managed all content touchpoints, including blogs, transactional and promotional communication, ensuring all the content is brand consistent and SEO optimized across all marketing channels - mobile app, website, social media, emails, and offline channels.

She has extensive experience in Email marketing with knowledge of marketing automation tools, such as Oracle Responsys and Netcore Smartech. As part of her role in Marketing Communications teams, she has handled in-house content management systems, cross-channel marketing programs, transactional and promotional messaging, and large-scale marketing programs to drive business growth.

During her tenure at Oxigen Services Pvt. Ltd., a payment wallet company, she developed a keen interest in Volunteering. She participated in the E&Y Global Partnership Summit held in New Delhi in 2017 and earned laurels as part of the Behind the Scenes Team.

Neha is passionate about secondary research, marketing analytics, and medical writing. In her free time, Neha loves to read fiction, experiment with new recipes, and read stories to her daughter Ashna or play with her.

See less

Articles from Neha

Free SARS-CoV-2 spike protein fragments may trigger platelet activation and clot formation in COVID-19

Free SARS-CoV-2 spike protein fragments may trigger platelet activation and clot formation in COVID-19

Efficacy and safety of a 3rd dose of mRNA-1273 SARS-CoV-2 vaccine

Efficacy and safety of a 3rd dose of mRNA-1273 SARS-CoV-2 vaccine

Oral Nirmatrelvir's effects on long COVID symptoms

Oral Nirmatrelvir's effects on long COVID symptoms

SARS-CoV-2 BA.2 poses greater risk to global health than BA.1

SARS-CoV-2 BA.2 poses greater risk to global health than BA.1

Pets living in households with COVID-19 are high likely to seroconvert and become ill

Pets living in households with COVID-19 are high likely to seroconvert and become ill

How a COVID support team mitigated SARS-CoV-2 transmission within a university community

How a COVID support team mitigated SARS-CoV-2 transmission within a university community

Multi-omics identify COVID-19 severity predictors and prothrombotic signatures in patients with end-stage kidney disease

Multi-omics identify COVID-19 severity predictors and prothrombotic signatures in patients with end-stage kidney disease

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Study reveals Omicron sub-lineages BA.4 and BA.5 escape neutralizing antibodies elicited in response to BA.1 infection

Study reveals Omicron sub-lineages BA.4 and BA.5 escape neutralizing antibodies elicited in response to BA.1 infection

Fourth dose of COVID-19 vaccine reduced death among hospitalized patients during Omicron wave in Israel

Fourth dose of COVID-19 vaccine reduced death among hospitalized patients during Omicron wave in Israel

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.